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Synovial sarcomas are sott tissue tumors that occur mainly in 
adolescents and young adults, The chromosomal translocation 
(X; 18)(p 11.2;ql 1.2) is found in the majority of these sarcomas 
(1) and, as such, is thought to play a causative role in 
tumor formation. The occurrence of two related but distinct 
breakpoints in X p ll .2  has been reported by us and others 
using tumor-derived somatic cell hybrids and metaphase and 
interphase fluorescent in situ hybridization (FISH) on primary 
tumor samples in conjunction with breakpoint-spanning YACs 
(2-5). These YACs contain several X chromosome-specific 
low copy repeat sequences, among which two ornithine amino­
transferase-like pseudogene clusters, OATL1 and OATL2. 
Interestingly, we found that the occurrence of the two 
breakpoints correlates with the histologic phenotypes of the 
tumors, i.e., those with a breakpoint near the OATL1 region 
display a biphasic morphology, whereas most of the tumors with 
a breakpoint near OATL2 are monophasic (4,6,7). Recently, we 
isolated a chimaeric genomic (X; 18) fragment containing the 
synovial sarcoma-specific breakpoint region (8). By using 
chromosome 18-specific single copy probes from this fragment, 
rearrangements were observed in tumors carrying translocation 
breakpoints in the vicinity of either OATL1 or OÀTL2, 
suggesting that a single gene on chromosome 18 is probably 
involved in both types of tumors (8). Subsequently, a chimaeric 
(X;18) cDNA clone was isolated by Clark et al. (9) and the 
contributing genes were referred to as SYT (chromosome 18) 
and SSX (X chromosome). Via RT-PCR, using SYT and SSX-  
specific primers, a 585 basepair (bp) chimaeric fragment could 
be amplified in several synovial sarcomas. No details were 
provided by these authors about the cytogenetic and/or histol­
ogic characteristics of the tumors studied.
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Figure 1. RT-PCR products (35 cycles; 96°C 1 min; 47°C 1 min; 72°C 3 
min) of synovia] sarcoma ( 1- 9) and control renal tumor ( 10 ) samples, after 
agarose gel (2%) electrophoresis. As primers SYT: 5' CAACAGCAAGA- 
TGCATACCA 3' and SSX: 5 ’ CACTTGCTATGCACCTGATG 3' were used 
(see Fig. 2). Synovial sarcomas: lanes 1 and 5-9: 28775/90, 2374/90, 23.303B, 
KN, 4873/92 and 20521/88 (see refs 4,7); lane 2: 293090 (unpublished case); 
lane 3: somatic cell hybrid Hlsynsarc (ref. 10); lane 4: a tumor-derived cell 
line (unpublished result). Fragment lengths are indicated in base pairs.
We have carried out RT-PCR on RNAs extracted from a 
series of nine independent synovial sarcomas, including one 
cell line and one tumor-derived somatic cell hybrid using the 
SYT/SSX primer set reported by Clark et a l  (9). As a control 
a t(X;18)-negative renal cell carcinoma was included in our 
assays. All synovial sarcomas used in this series have been 
subjected to breakpoint analysis by FISH (4,7 and unpublished
[-------------- SYT------------------- >
1 CAACAGCAAG ATGCATACC A GGGACCACCT CCACAACAGG GATATCCACC 
1 CAACAGCAAG ATGCATACCA GGGACCACCT CCACAACAGG GATATCCACC
c -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
5 1  CCAGCAGCAG CAGTACCCAG GGCAGCAAGG TTACCCAGGA CAGCAGCAGG 
5 1  CCAGCAGCAG CAGTACCCAG GGCAGCAAGG TTACCCAGGA CAGCAGCAGG
1 0 1  GCTACGGTCC TTCACAGGGT GGTCCAGGTC CTCAGTATCC TAACTACCCA 
1 0 1  GCTACGGTCC TTCACAGGGT GGTCCAGGTC CTCAGTATCC TAACTACCCA
1 5 1  CAGGGACAAG GTCAGCAGTA TGGAGGATAT AGACCAACAC AGCCTGGACC 
1 5 1  CAGGGACAAG GTCAGCAGTA TGGAGGATAT AGACCAACAC AGCCTGGACC
2 0 1  ACCACAGCCA CCCCAGCAGA GGCCTTATGG ATATGACCAG ATCATGCCCA 
2 0 1  ACCACAGCCA CCCCAGCAGA GGCCTTATGG ATATGACCAG ATCATGCCCA 
— .------- .----------c h ro m o s o m e  1 8 -------------------------------------] [ ------»— ------
2 5 1  AGAAGCCAGC AGAGGACGAA AATGATTCGA AGGGAGTGTC AGAAGCATCT 
2 5 1  AGAAGCCAGC AGAGGAAGGA AATGATTCGG AGGAAGTGCC AGAAGCATCT
------------------------ A—A----------------A----- A----- À----------------
<------------ S S X 1-S S X 2---------- ]
3 0 1  GGCCCACAAA ACGATGGGAA ACAACTGCAC CCCCCAGGAA AAOCAAATAT 
3 0 1  GGCCCACAAA ATGATGGGAA AQAGCTGTQC CCCCCGGGAA AACCAACTAC
-----------------A-------------- A-A-—AA----------A--«——A----A-- A
»
3 5 1  TTCTGAGAAG ATTXATAAGA GATCTGGACC CAAAAGGGGG AAACATGCCT 
3 5 1  CTCTGAGAAG ATTCACGAGA GATCTGGACC CAAAAGGGGG GAACATGCCT
A------------------ A-A A----- --------------------- --------- A-------- ----
4 0 1  GGACCCACAG ACTGCGTGAG AGAAAGCAGC ÇGGTGATTTA TGAAGAGATC 
4 0 1  GGACCCACAG ACTGCGTGAG AGAAAACAGC TGGTGATTTA TGAAGAGATC 
----- ---------------- c h ro m o s o m e  X--------A.----------------------- ------------ ----------------
4 5 1  AGCGACCCTG AGGAAGATGA CGAGTAACTC CCCTGKJGGGA TACGACÀCAT 
4 5 1  AGCGACCCTG AGGAAGATGA CGAGTAACTC CCCTCAGGGA TACGACACAT
—--------------- -------------------- Stop-—'------ A Â----—-- —
5 0 1  GCCCTTGATG AGAAGCAGAA CGTGGTGACC TTTCACGAAC ATGGGCATGG 
5 0 1  GCCCATGATG AGAAGCAGAA CGTGGTGACC TTTCACGAAC ATGGGCATGG
--------------------A --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
<-----------------SSX------------------ ]
5 5 1  CTGCGGCTCC CTCGTCATCA GGTGCATAGC AAGTG =  SYT-SSX1 
5 5 1  CTGCGGACCC CTCGTCATCA GGTGCATAGC AAGTG -  SY T-SSX 2 
------------AA------------------------------------------------------------ ]
Figure 2. Comparison of the two different types o f  sequences found among 
the SYT/SSX PCR products displayed in Figure 1. Base differences are 
indicated by arrowheads. A lu l  restriction sites are underlined. Locations of 
SYT, SSX and SSX 1/2 specific primers are overlined (with directional arrows). 
The end o f  the open reading frame is indicated by ‘stop’. The chromosomal 
regions of origin are marked between brackets.
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